human
polyclon
antibodi
also
call
intraven
immunoglobulin
ivig
simpli
immunoglobulin
g
igg
prepar
plasma
gener
popul
convalesc
human
donor
use
therapeut
agent
treat
varieti
diseas
immunodefici
infect
howev
natur
voluntari
donat
human
plasma
product
human
ivig
therapeut
limit
shortag
suppli
also
great
concern
potenti
transmiss
human
diseas
donor
patient
animalderiv
polyclon
antibodi
also
use
therapeut
certain
diseas
indic
one
lifesav
antivenom
deriv
hors
animalderiv
polyclon
antibodi
product
also
suffer
signific
limit
chief
among
sever
advers
effect
allerg
reaction
caus
high
immunogen
product
address
limit
human
animalderiv
polyclon
antibodi
sab
biotherapeut
inc
develop
transchromosom
tc
bovin
platform
capabl
produc
larg
quantiti
highli
potent
fullyhuman
polyclon
tc
bovin
bovin
immunoglobulin
gene
genet
inactiv
gene
target
ig
function
reconstitut
human
artifici
chromosom
hac
compris
entir
unrearrang
human
immunoglobulin
heavychain
high
kappachain
higk
lambdachain
higl
germlin
loci
consequ
tc
cattl
express
fullyhuman
igg
higg
optim
genet
element
hac
involv
b
cell
signal
ig
class
switch
recombin
physiolog
level
higg
produc
blood
tc
bovin
mgml
lead
product
g
higg
tc
bovin
per
equal
import
tc
cattl
hyperimmun
pathogen
choic
produc
highli
potent
pathogenspecif
higg
success
use
treat
list
viral
bacteri
infect
diseas
anim
model
higg
product
enter
human
clinic
build
upon
tc
bovin
platform
recent
initi
effort
establish
tc
goat
capra
aegagru
hircu
system
produc
higg
smaller
ungul
develop
tc
system
small
ungul
speci
goat
better
suit
produc
smaller
volum
higg
certain
applic
includ
use
higg
diagnost
reagent
serolog
test
emerg
diseas
therapeut
spotti
outbreak
infecti
diseas
andor
person
therapeut
higg
product
target
specif
diseas
goat
also
offer
advantag
shorter
gestat
period
grow
adult
size
much
faster
larger
ungul
decreas
time
herd
develop
much
lower
cost
furthermor
larg
number
tc
goat
quickli
produc
plasma
suffici
number
anim
includ
plasma
pool
strategi
ensur
greater
lot
lot
consist
first
step
establish
tc
goat
system
investig
whether
hac
engin
function
goat
support
express
higg
tc
goat
sera
toward
goal
transfer
hac
wildtyp
goat
fetal
fibroblast
cell
follow
somat
cell
nuclear
transfer
scnt
clone
tc
goat
report
produc
tc
caprin
express
higg
pbmc
sera
also
demonstr
influenza
immun
studi
tc
caprin
hyperimmun
respond
well
pathogen
choic
produc
pathogenspecif
higg
serum
furthermor
function
studi
elicit
higg
demonstr
high
neutral
activ
virus
vitro
previous
engin
hac
name
compris
entir
human
ig
genet
repertoir
germlin
configur
regulatori
genom
sequenc
involv
preb
cell
receptor
prebcr
bcr
signal
b
cell
develop
mediat
human
ig
class
switch
recombin
replac
respect
genom
sequenc
ungul
bovin
demonstr
tc
bovin
system
ungul
regulatori
sequenc
engin
hac
allow
high
level
higg
express
higg
subclass
distribut
domin
close
mimick
higg
express
reason
ungul
regulatori
element
due
high
similar
sequenc
among
ungul
may
also
render
hac
function
well
tc
goat
base
rational
establish
singl
cellderiv
tc
goat
fibroblast
cell
coloni
transfer
goat
fetal
fibroblast
cell
via
microcellmedi
chromosom
transfer
mmct
use
produc
tc
goat
fibroblast
nuclear
donor
tc
goat
product
scnt
total
clone
embryo
gener
use
five
contain
fetal
fibroblast
coloni
transfer
estrussynchron
tabl
pregnanc
check
conduct
ultrasonographi
day
gestat
confirm
recipi
pregnant
tabl
pregnanc
obtain
coloni
two
pregnanc
abort
day
day
gestat
one
mummifi
fetu
lost
day
gestat
one
pregnanc
initi
coloni
went
term
result
birth
healthi
tc
goat
fig
confirm
hac
retain
tc
goat
conduct
genom
pcr
analysi
peripher
blood
mononuclear
cell
pbmc
isol
tc
goat
birth
pcr
primer
specif
differ
domain
hac
tabl
shown
fig
pcr
perform
posit
confirm
presenc
structur
integr
hac
tc
goat
also
subject
pcr
product
sanger
sequenc
valid
specif
pcr
evalu
human
igg
level
tc
goat
human
igg
elisa
perform
tc
goat
serum
sampl
collect
week
month
age
three
human
igg
detect
tc
goat
sera
similar
observ
tc
bovin
bovin
ig
gene
intact
similar
development
product
higg
tc
goat
also
confirm
western
blot
experi
purifi
igg
sampl
collect
sera
fig
investig
whether
tc
goat
mount
higgmedi
humor
immun
respons
antigen
immun
tc
goat
age
month
inactiv
viru
first
second
round
vaccin
follow
recombin
third
fourth
vaccin
day
post
fourth
vaccin
serum
sampl
ml
per
collect
collect
immun
goat
higg
purifi
antigenspecif
higg
titer
analyz
higg
elisa
shown
fig
bind
detect
neg
control
higg
isol
unimmun
tc
anim
high
titer
higg
detect
higg
purifi
sera
tc
goat
post
immun
conclud
hac
confer
tc
goat
capabl
gener
antigenspecif
higg
respons
antigen
challeng
conduct
viru
neutral
assay
investig
potenc
purifi
higg
virus
demonstr
higg
purifi
immun
tc
goat
high
neutral
titer
activ
viru
tabl
indic
higg
elicit
immun
regimen
tc
goat
neutral
live
virus
high
potenc
vitro
address
challeng
insuffici
suppli
higg
extens
research
carri
develop
altern
strategi
product
larg
quantiti
higg
recent
report
success
establish
tc
bovin
platform
allow
first
time
product
larg
quantiti
highli
potent
higg
g
higg
per
anim
per
month
tc
anim
rais
biosecur
facil
anim
pathogen
control
measur
place
tc
platform
elimin
diseas
transmiss
human
donor
patient
common
concern
use
human
ivig
product
moreov
tc
anim
hyperimmun
pathogen
choic
formul
proprietari
adjuv
develop
sab
biotherapeut
produc
high
titer
pathogenspecif
higg
overcom
low
potenc
problem
associ
human
ivig
produc
gener
human
donor
popul
inde
use
sever
emerg
viral
infect
diseas
target
demonstr
anim
model
pathogenspecif
higg
produc
tc
bovin
system
highli
potent
treat
alreadi
clinic
report
describ
effort
extend
tc
technolog
smaller
ungul
goat
caprin
certain
biomed
applic
serolog
test
therapeut
small
patient
popul
desir
produc
smaller
volum
higg
product
also
highli
desir
capabl
swiftli
establish
tc
anim
heard
therapeut
higg
product
respond
sudden
outbreak
infecti
diseas
regard
goat
offer
advantag
much
shorter
reproduct
cycl
physic
matur
time
larger
ungul
furthermor
addit
allow
plasma
pool
strategi
employ
larg
number
tc
anim
greater
lot
lot
consist
tc
goat
use
produc
personalizedtherapeut
afford
cost
success
develop
first
tc
goat
product
pathogenspecif
higg
demonstr
feasibl
tc
technolog
goat
howev
first
step
effort
fulli
establish
tc
goat
system
goat
endogen
ig
gene
still
intact
tc
caprin
report
like
demonstr
tc
endogen
goat
ig
gene
predominantli
express
human
ig
gene
goat
b
cell
competit
goat
ig
gene
human
ig
gene
would
sever
suppress
express
human
ig
gene
lead
low
level
express
higg
phenomenon
observ
tc
bovin
system
bovin
ig
gene
addit
express
endogen
goat
ig
gene
may
also
lead
format
chimer
certain
percentag
produc
antibodi
light
chain
goat
origin
heavi
chain
human
origin
vice
versa
address
issu
initi
effort
genet
inactiv
goat
ig
gene
greatli
enhanc
product
higg
tc
goat
system
prevent
chimer
antibodi
product
strategi
proven
effect
tc
recent
knock
goat
ig
heavi
chain
lambda
light
chain
kappa
light
chain
gene
tripl
knockout
goat
primari
fibroblast
cell
tripl
knockout
cell
line
use
tc
goat
product
goal
achiev
higg
product
level
tc
goat
system
compar
goat
igg
level
wild
type
object
achiev
tc
bovin
system
test
tc
caprin
fulli
fertil
recent
bred
wild
type
ram
time
submit
report
tc
caprin
detect
pregnant
two
live
fetus
ultrasound
gestat
stage
day
normal
fertil
tc
goat
import
quickli
expand
tc
herd
success
tc
goat
establish
pregnanc
encourag
even
though
still
await
outcom
full
term
pregnanc
tc
goat
hyperimmun
multipl
time
vaccin
contain
strong
adjuv
andor
immun
stimul
lead
product
highli
potent
neutral
higg
pathogen
choic
larg
herd
tc
goat
produc
quickli
tc
caprin
system
provid
patient
higg
product
highli
potent
safe
low
cost
immun
studi
follow
function
character
higg
elicit
tc
caprin
demonstr
proof
concept
novel
tc
caprin
system
therapeut
applic
also
intent
higg
product
produc
hyperimmun
tc
goat
use
diagnost
reagent
human
antibodi
desir
summari
success
extend
tc
technolog
goat
lead
product
tc
goat
express
higg
sera
also
demonstr
tc
goat
hyperimmun
pathogen
choic
elicit
high
titer
pathogenspecif
higg
see
fig
tabl
therefor
tc
goat
system
may
provid
novel
solut
product
targetspecif
high
titer
human
antibodi
therapeut
diagnost
applic
ovari
domest
goat
capra
aegagru
hircu
obtain
local
abattoir
springvil
ut
usa
transport
laboratori
within
hour
collect
ovari
transport
salin
contain
uml
penicillin
streptomycin
arriv
laboratori
ovari
process
use
slice
techniqu
previous
oocyt
three
layer
compact
cumulu
cell
homogen
cytoplasm
use
vitro
matur
perform
previous
publish
briefli
cumulu
oocyt
complex
coc
cultur
group
plate
contain
ml
matur
medium
gibco
grand
island
ny
usa
contain
volvol
fetal
bovin
serum
fb
lh
fsh
gl
gentamicin
hour
cultur
cumulu
cell
remov
matur
oocyt
vertex
coc
min
tlhepe
contain
mgml
hyaluronidas
nuclear
matur
confirm
presenc
first
polar
bodi
oocyt
stage
term
mii
oocyt
goat
fibroblast
cultur
hyclon
medium
supplement
volvol
fc
hyclon
logan
ut
usa
microcel
purifi
cho
clone
retain
describ
goat
fibroblast
fuse
microcel
use
polyethylen
glycol
peg
fuse
cell
select
zeocin
life
technolog
carlsbad
ca
usa
day
zeocinresist
clone
screen
confirm
presenc
hac
cell
subsequ
use
scnt
haccontain
fetal
fibroblast
cell
cultur
dmemhighglucos
medium
hyclon
logan
ut
usa
supplement
volvol
fb
uml
penicillinstreptomycin
fibroblast
grown
confluenc
use
nuclear
donor
cell
scnt
hour
serum
starvat
fb
scnt
perform
describ
briefli
polar
bodi
metaphas
plate
remov
mii
oocyt
singl
donor
cell
subsequ
transfer
perivitellin
space
enucl
oocyt
fusion
perform
sorbitol
fusion
medium
mm
calcium
mm
magnesium
mm
hepe
gml
bsa
singl
dc
electr
puls
kvcm
microsecond
fusion
donor
cell
oocyt
cytoplasm
evalu
microscopi
minut
puls
fusion
embryo
held
synthet
oviduct
fluid
sof
fuse
embryo
activ
hour
onset
matur
exposur
ionomycin
minut
follow
incub
mm
dmap
cycloheximid
embryo
cultur
oil
droplet
sof
medium
hour
transfer
estru
synchron
recipi
femal
recipi
synchron
embryo
transfer
conduct
describ
briefli
syncrit
vagin
spong
anim
health
suppli
ulladulla
australia
contain
mg
flurogesteron
acet
place
intravagin
day
estru
occur
hour
spong
remov
ovul
usual
occur
hour
occurr
estru
fourteen
domest
goat
year
age
capra
aegagru
hircu
use
recipi
embryo
transfer
somat
cell
nuclear
transfer
pregnanc
establish
surgic
transfer
onecel
stage
embryo
oviduct
synchron
recipi
exhibit
estru
within
hour
scnt
pregnanc
confirm
done
day
embryo
transfer
transabdomin
ultrasonographi
anim
contain
viabl
conceptu
determin
presenc
heartbeat
consid
pregnant
birth
offspr
allow
remain
dam
nurs
freeli
wean
month
age
dna
extract
goat
whole
blood
collect
birth
tc
goat
use
gentra
puregen
kit
qiagen
analys
implement
previous
pcr
product
run
agaros
gel
primer
sequenc
provid
tabl
detect
human
igg
tc
goat
sera
human
igg
elisa
perform
maxisorp
immuno
elisa
plate
describ
briefli
goat
antihuman
iggfc
bethyl
montgomeri
tx
usa
use
captur
antibodi
goat
antihuman
iggfc
antibodi
hrp
conjug
bethyl
montgomeri
tx
usa
use
detect
antibodi
human
refer
serum
known
human
igg
concentr
bethyl
montgomeri
tx
usa
use
standard
wild
type
goat
serum
use
neg
control
influenza
grown
embryon
egg
incub
hour
allanto
fluid
harvest
titrat
plaqu
assay
viru
inactiv
bpl
hour
inactiv
test
ha
inject
three
embryon
egg
incub
hour
go
hour
allanto
fluid
test
ha
pool
neg
posit
sampl
insert
three
embryon
egg
incub
hour
egg
put
hour
allanto
fluid
test
ha
bpl
repeat
necessari
sequenc
synthes
genscript
deliv
vector
amplifi
use
tcttgcacttgtcacgaattcggataagatttgtctgggccatcatgctgtga
tgtgtgagttttgtctctcccctttggaatctcgggcacat
gener
fragment
human
fc
hfc
vector
express
vector
invivogen
inc
cttgtcacgaattcggataagatttgtctgggccatcatgctgtga
gcacgtgggcttgcttctcccctttggaatctcgggcacat
rabbit
fc
rfc
express
vector
invivogen
inc
pcr
clone
conduct
use
clonez
system
genescript
subclon
compet
cell
invitrogen
vector
transient
express
recombin
accomplish
use
cell
life
technolog
transfect
kit
life
technolog
follow
standard
protocol
day
supernat
centrifug
rpm
min
filter
emd
millipor
prior
purif
recombin
purifi
protein
column
recombin
use
antigen
tc
goat
vaccin
recombin
use
coat
antigen
human
igg
elisa
tc
goat
immun
four
time
interv
bplinactiv
viru
influenza
formul
given
tc
goat
via
intraderm
id
inject
first
vaccin
mg
per
dose
second
vaccin
mg
per
dose
recombin
mg
per
dose
formul
given
tc
goat
via
intramuscular
inject
third
fourth
vaccin
forti
ml
serum
per
collect
collect
immun
tc
goat
day
day
fourth
vaccin
antibodi
purif
human
igg
tc
goat
sera
first
affinitypurifi
antihuman
igg
column
igselect
ge
healthcar
life
scienc
marlborough
usa
human
igg
purifi
passag
antigoat
igg
affin
column
remov
remain
goat
igg
purifi
human
igg
igg
concentr
mgml
sterilefilt
pb
buffer
immunoglobulin
heavi
light
chain
purifi
human
igg
goat
igg
separ
sd
page
use
precast
bistri
gel
invitrogen
transfer
polyvinyliden
difluorid
membran
directli
probe
donkey
antihigg
h
l
specif
horseradish
peroxidas
hrp
conjug
antibodi
jackson
immunoresearch
higg
heavi
chain
light
chain
detect
determin
haspecif
higg
titer
nunc
maxisorp
elisa
plate
coat
overnight
recombin
pb
plate
wash
pbst
pb
tween
block
room
temperatur
rt
hour
casein
thermo
pb
wash
pbst
purifi
human
igg
immun
tc
goat
neg
control
human
igg
purifi
unimmun
tc
anim
ad
plate
serial
dilut
pbst
incub
hr
rt
follow
wash
pbst
goat
antihuman
iggfc
conjug
horseradish
peroxidas
hrp
bethyl
ad
plate
incub
hr
rt
final
wash
pbst
bound
ha
antibodi
detect
colorimetr
use
tmb
substrat
kit
absorb
read
micropl
reader
nm
mdck
cell
maintain
minimum
essenti
medium
mem
supplement
volvol
fb
serial
dilut
purifi
human
igg
neg
control
serumfre
mem
tpcktreat
trypsin
sigma
mix
equal
volum
viru
pfuml
incub
h
confluent
mdck
cell
format
wash
twice
pb
mixtur
antibodyviru
ad
cell
incub
h
antibodyviru
mixtur
remov
fix
plate
stain
crystal
violet
minut
rt
determin
viabil
cultur
cell
